Skip to content

Bookmark and Share

Seminar: Priority Setting in Health: Supporting health technology assessment in the Americas

 CGD Event Invitation:

The Center for Global Development and Pan American Health Organization present

Priority Setting in Health: Supporting health technology assessment in the Americas

Featuring

Harvey V. Fineberg - President US Institute of Medicine

Mirta Roses Periago - Director Pan American Health Organization PAHO/WHO

Moderated by
Amanda Glassman Director of Global Health Policy Center for Global Development

Donors, policymakers, and practitioners continuously make broad impact decisions about which type of patients receive what interventions,
when, and at what cost. These decisions--as consequential as they are--often result from ad hoc, nontransparent processes driven more by inertia and interest groups than by science, ethics, and the public interest.

When

Tuesday, October 23, 2012 3:00 pm - 5:00 pm

 Where

The George Washington University
City View Room - 1957 E Street, NW, 7th Floor - Washington DC 20052

 Faragut West Metro ( Orange and Blue lines)
Faragut North Metro (Red line)

Kyla Lawrence Events Coordinator This e-mail address is being protected from spambots. You need JavaScript enabled to view it 202-416-4000


The event will feature the Center for Global Development's new report, Priority-Setting in Health: Building Institutions for Smarter Public Spending and
PAHO's recent Health Technology Assessment resolution
.: http://bit.ly/Rdyl8q

 


 Priority-Setting in Health:
Building Institutions for Smarter Public Spending

A report of the Center for Global Development’s Priority-Setting Institutions for Global Health Working Group

Amanda Glassman and Kalipso Chalkidou, Co-chairs – 2012

Available online PDF [101p.] at: http://bit.ly/LYHE9Z

“…….Health donors, policymakers, and practitioners continuously make life-and-death decisions about which type of patients receive what interventions, when, and at what cost. These decisions—as consequential as they are—often result from ad hoc, nontransparent processes driven more by inertia and interest groups than by science, ethics, and the public interest. The result is perverse priorities, wasted money, and needless death and illness.

Examples abound: In India, only 44 percent of children 1 to 2 years old are fully vaccinated, yet open-heart surgery is subsidized in national public hospitals. In Colombia, 58 percent of children are fully vaccinated, but public monies subsidize treating breast cancer with Avastin, a brand-name medicine considered ineffective and unsafe for this purpose in the United States.

Reallocating a portion of public and donor monies toward the most cost-effective health interventions would save more lives and promote health equity. The obstacle is not a lack of knowledge about what interventions are best, but rather that too many low- and middle-income countries lack the fair processes and institutions needed to bring that knowledge to bear on funding decisions.

With that in mind, the Center for Global Development’s Priority-Setting Institutions for Global Health Working Group recommends creating and developing fair and evidence-based national and global systems to more rationally set priorities for public spending on health. The group calls for an interim secretariat to incubate a global health technology assessment facility designed to help governments develop national systems and donors get greater value for money in their grants…”

Content:


Executive summary

Chapter 1 Finite resources, unlimited demand

A framework of de facto rationing mechanisms

The timing of rationing: ex ante and ex post

The rationing implications of allocation between areas and within levels of the health system

In a practical sense, however, priority is often revealed by action and spending

Rationing is constrained by historical and political processes

Why the Priority-Setting Institutions in Health Working Group?

Chapter 2 The opportunity: evidence, economies, and donor agendas converge to make explicit rationing necessary and possible

Force 1: A growing body of evidence suggests huge health gains are possible

Force 2: Public spending on health is growing in low- and middle-income countries

Force 3: Donors are beginning to restrict health aid flows, putting renewed emphasis on impact, co-financing, and value for money

Chapter 3 Considering cost-effectiveness: the moral perspective

The cost-effectiveness landscape in global health 1

The moral case

Challenges addressed

Chapter 4 Progress on policy instruments for explicit priority setting

Essential medicines lists

Health benefits plans

National Immunization Technical Advisory Committees

Health technology assessment agencies

Case studies

Chapter 5 Donors and decisions

Development assistance partners’ support to recipient country priority-setting processes

GAVI Alliance prioritization mechanisms

Global Fund prioritization mechanisms

Chapter 6 Building institutions for explicit priority setting

Institutionalizing health technology assessment systems in low- and middle-income countries

Chapter 7 Recommendations for action

Looking ahead

Regional Office of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel: +1-(202) 974-3000 Fax: +1-(202) 974-3663